Lilly’s “Open Clinical Intelligence Network” Aligned With Substitutability

Tom Krohn, an attendee to the recent Health IT Meeting at Harvard (“ITdotHealth II”), is the business lead for the Eli Lilly Clinical Open Innovation team. Leading up to the meeting, he wrote about the ways his team’s approach aligns with SMART.